Outcomes at 12 month follow-up | Intervention group mean (SD) | Control group mean (SD) | *p value |
EQ-5D score (0–1) | |||
Entire sample | 0.64 (0.32) n=395 | 0.61 (0.32) n=391 | 0.09 |
<44 years | 0.68 (0.33) n=69 | 0.54 (0.34) n=71 | 0.012* |
45–60 years | 0.58 (0.35) n=132 | 0.59 (0.35) n=131 | 0.88 |
>60 years | 0.67 (0.28) n=194 | 0.65 (0.27) n=89 | 0.37 |
EQ-5D VAS (0–100) | |||
Entire sample | 68.8 (18.6) n=397 | 63.9 (20) n=394 | 0.0007* |
<44 years | 67.62 (19.1) n=69 | 58.3 (20.2) n=71 | 0.003* |
45–60 years | 66.1 (18.6) n=135 | 62.0 (19.5) n=133 | 0.13 |
>60 years | 71.1 (18.2) n=193 | 67.3 (19.8) n=190 | 0.07 |
Adherence | |||
Did not attend | 30 (8%) | NA | NA |
Attended <16 weeks | 123 (32%) | NA | NA |
Attended 16 weeks | 247 (62%) | NA | NA |
↵* Significant (p<0.05) according to Mann–Whitney test.
EQ5D, EuroQol—5 Dimensions; VAS, visual analogue scale.